BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3734147)

  • 1. Treatment of schizophrenia with verapamil.
    Price WA; Pascarzi G; Giannini AJ
    J Clin Psychopharmacol; 1986 Aug; 6(4):249. PubMed ID: 3734147
    [No Abstract]   [Full Text] [Related]  

  • 2. Antipsychotic effects of verapamil in schizophrenia.
    Price WA
    Hillside J Clin Psychiatry; 1987; 9(2):225-30. PubMed ID: 3323023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Verapamil in the treatment of chronic schizophrenia.
    Tourjman SV; Bloom DM; Nair NP
    Psychopharmacol Bull; 1987; 23(1):227-9. PubMed ID: 3602324
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of verapamil to treat negative symptoms in schizophrenia.
    Price WA; Pascarzi GA
    J Clin Psychopharmacol; 1987 Oct; 7(5):357. PubMed ID: 3680609
    [No Abstract]   [Full Text] [Related]  

  • 5. Verapamil in the treatment of schizophrenia.
    Wells BG
    DICP; 1990 Sep; 24(9):838-40. PubMed ID: 2260342
    [No Abstract]   [Full Text] [Related]  

  • 6. Verapamil in refractory schizophrenia: a case report.
    Bloom DM; Tourjman SV; Nair NP
    Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(2-3):185-8. PubMed ID: 3628827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of verapamil administration on negative symptoms of chronic schizophrenia.
    Uhr SB; Jackson K; Berger PA; Csernansky JG
    Psychiatry Res; 1988 Mar; 23(3):351-2. PubMed ID: 3387506
    [No Abstract]   [Full Text] [Related]  

  • 8. Verapamil in treatment of severe schizophrenia.
    Schepelern S; Køster A
    Acta Psychiatr Scand; 1987 May; 75(5):557-8. PubMed ID: 2886012
    [No Abstract]   [Full Text] [Related]  

  • 9. A negative, double-blind, placebo-controlled, clinical trial of verapamil in chronic schizophrenia.
    Grebb JA; Shelton RC; Taylor EH; Bigelow LB
    Biol Psychiatry; 1986 Jun; 21(7):691-4. PubMed ID: 3518822
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of adjunctive verapamil administration in chronic schizophrenic patients.
    Bartko G; Horvath S; Zador G; Frecska E
    Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(3):343-9. PubMed ID: 1677775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of verapamil on tardive dyskinesia and psychosis in schizophrenic patients.
    Reiter S; Adler L; Angrist B; Peselow E; Rotrosen J
    J Clin Psychiatry; 1989 Jan; 50(1):26-7. PubMed ID: 2562952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Verapamil in acute psychosis.
    Price WA; Giannini AJ
    Psychosomatics; 1986 Nov; 27(11):797. PubMed ID: 3797612
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical and biochemical effects of verapamil administration to schizophrenic patients.
    Pickar D; Wolkowitz OM; Doran AR; Labarca R; Roy A; Breier A; Narang PK
    Arch Gen Psychiatry; 1987 Feb; 44(2):113-8. PubMed ID: 3545130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steady-state cerebrospinal fluid transfer of verapamil and metabolites in patients with schizophrenia.
    Narang PK; Blumhardt CL; Doran AR; Pickar D
    Clin Pharmacol Ther; 1988 Nov; 44(5):550-7. PubMed ID: 3180637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticholinergic overdose induced torsade de pointes successfully treated with verapamil.
    Liao WB; Bullard MJ; Kuo CT; Hsiao CT; Chu PH; Chiang CW
    Jpn Heart J; 1996 Nov; 37(6):925-31. PubMed ID: 9057687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Verapamil for the treatment of clozapine-induced persistent sinus tachycardia in a patient with schizophrenia: a case report and literature review.
    Das P; Kuppuswamy PS; Rai A; Bostwick JM
    Psychosomatics; 2014; 55(2):194-5. PubMed ID: 23820380
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapeutic effect of verapamil in hypertension: an analysis of 52 cases].
    Zong JL; Wang JJ; Wen ZB
    Zhonghua Nei Ke Za Zhi; 1989 Apr; 28(4):216-7, 251. PubMed ID: 2805958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Verapamil and hypertension--(multicenter study of the efficacy and tolerance of delayed-action verapamil in the treatment of essential hypertension)].
    Kreuter U; Mühlemann M; Vogt E; Wohlwend MC
    Rev Med Suisse Romande; 1990 Jun; 110(6):551-8. PubMed ID: 2195624
    [No Abstract]   [Full Text] [Related]  

  • 19. Verapamil in treatment-resistant mania: an open trial.
    Barton BM; Gitlin MJ
    J Clin Psychopharmacol; 1987 Apr; 7(2):101-3. PubMed ID: 3294919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Verapamil concentrations in cerebrospinal fluid after oral administration.
    Doran AR; Narang PK; Meigs CY; Wolkowitz OM; Roy A; Breier A; Pickar D
    N Engl J Med; 1985 May; 312(19):1261-2. PubMed ID: 3990723
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.